期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (10)
Introduction: Microglia-mediated inflammatory responses play a crucial role in aging-related neurodegenerative diseases. The TXNIP/NLRP3 pathway is a ......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (11)
Background: Although Semaphorin 3A (Sema3A)/ Neuropilin-1(NRP1)/Plexin A1 is one of the important targets in bone metabolism, few studies are performe......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (10)
Objective: To summarize and assess the effects of probiotic preparations on inflammatory cytokine levels in patients with Chronic Kidney Disease (CKD)......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (9)
Background: In recent years, the incidence of sudden deafness has gradually increased, with a very limited understanding of its etiology and pathogene......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (11)
Background: gamma-Poly-Glutamic Acid (gamma-PGA) is a naturally occurring homo-polyamide produced by various strains of Bacillus. It is made from repe......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (12)
Pyroptosis is a new type of pro-inflammatory programmed cell death identified over the last few years and has since attracted researchers' attention. ......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (6)
Background: The quality of traditional Chinese medicine (TCM), reflected by its bioactive compounds and associated contents, is directly linked to its......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (12)
Background: The pathogenesis of Severe Acute Pancreatitis (SAP) is mediated substantially by dysfunctions in the intestinal barrier. Euphorbia kansui ......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (10)
Background: Cistanche tubulosa is a tonic in traditional Chinese medicines and has a broad spectrum of biological activity, including anti-inflammator......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (6)
Background: Plants produce thousands of chemically diverse secondary metabolites, many of which have valuable pharmaceutical properties. There is much......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (11)
Background: Rheumatoid Arthritis (RA) is a common connective tissue disease, characteristic of chronic and invasive synovitis in single or multiple jo......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (6)
Background: Biogenic synthesis of nanoparticles (NPs) is attractive due to their ecological benefits and cheap, rapid, and sustainable nature. Among t......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (12)
Background: Pulmonary arterial Hypertension (PH) is a chronic disease that ultimately progresses to right ventricular failure and death. Until now, th......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (9)
Background: Hepatocellular Carcinoma (HCC) is a primary liver cancer with high mortality. Paeoniflorin is a pinane monoterpene picroside with anti-tum......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2021; 22 (8)
Background: Pancreatic ductal adenocarcinoma (PDAC) is the most common and deadly cancer. Surgical resection is the only possible cure for pancreatic ......
